Sookyung Ryoo1, Jihoon Cha1, Suk Jae Kim1, Jin Wook Choi1, Chang-Seok Ki1, Keon Ha Kim1, Pyoung Jeon1, Jong-Soo Kim1, Seung-Chyul Hong1, Oh Young Bang2. 1. From the Departments of Neurology (S.R., S.J.K., O.Y.B.) and Radiology (J.C., J.W.C., K.H.K., P.J.), Laboratory Medicine and Genetics (C.-S.K.), and Neurosurgery (J.-S.K., S.-C.H.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 2. From the Departments of Neurology (S.R., S.J.K., O.Y.B.) and Radiology (J.C., J.W.C., K.H.K., P.J.), Laboratory Medicine and Genetics (C.-S.K.), and Neurosurgery (J.-S.K., S.-C.H.), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. neuroboy50@naver.com.
Abstract
BACKGROUND AND PURPOSE: Diagnosis of Moyamoya disease (MMD) is based on the characteristic angiographic findings. However, differentiating MMD from intracranial atherosclerotic disease (ICAD) is difficult. We compared vessel wall imaging findings on high-resolution magnetic resonance imaging between MMD and ICAD. METHODS: High-resolution magnetic resonance imaging was performed on 32 patients with angiographically proven MMD and 16 patients with acute infarcts because of ICAD. Bilateral internal carotid arteries and steno-occlusive middle cerebral artery were analyzed for wall enhancement and remodeling. RESULTS: Enhancement patterns and distribution were different. Most patients with MMD (90.6%) showed concentric enhancement on distal internal carotid arteries and middle cerebral arteries, whereas focal eccentric enhancement was observed on the symptomatic segment in ICAD. MMD was characterized by middle cerebral artery shrinkage; the remodeling index and wall area were lower in MMD than in ICAD (remodeling index, 0.19±0.11 versus 1.00±0.43; wall area, 0.32±0.22 versus 6.00±2.72; P<0.001). CONCLUSIONS: MMD was characterized by concentric enhancement on bilateral distal internal carotid arteries and shrinkage of middle cerebral artery, regardless of symptoms.
BACKGROUND AND PURPOSE: Diagnosis of Moyamoya disease (MMD) is based on the characteristic angiographic findings. However, differentiating MMD from intracranial atherosclerotic disease (ICAD) is difficult. We compared vessel wall imaging findings on high-resolution magnetic resonance imaging between MMD and ICAD. METHODS: High-resolution magnetic resonance imaging was performed on 32 patients with angiographically proven MMD and 16 patients with acute infarcts because of ICAD. Bilateral internal carotid arteries and steno-occlusive middle cerebral artery were analyzed for wall enhancement and remodeling. RESULTS: Enhancement patterns and distribution were different. Most patients with MMD (90.6%) showed concentric enhancement on distal internal carotid arteries and middle cerebral arteries, whereas focal eccentric enhancement was observed on the symptomatic segment in ICAD. MMD was characterized by middle cerebral artery shrinkage; the remodeling index and wall area were lower in MMD than in ICAD (remodeling index, 0.19±0.11 versus 1.00±0.43; wall area, 0.32±0.22 versus 6.00±2.72; P<0.001). CONCLUSIONS: MMD was characterized by concentric enhancement on bilateral distal internal carotid arteries and shrinkage of middle cerebral artery, regardless of symptoms.
Authors: Mahmud Mossa-Basha; Adam de Havenon; Kyra J Becker; Danial K Hallam; Michael R Levitt; Wendy A Cohen; Daniel S Hippe; Matthew D Alexander; David L Tirschwell; Thomas Hatsukami; Catherine Amlie-Lefond; Chun Yuan Journal: Stroke Date: 2016-06-07 Impact factor: 7.914
Authors: Ji Eun Park; Seung Chai Jung; Sang Hun Lee; Ji Young Jeon; Ji Ye Lee; Ho Sung Kim; Choong-Gon Choi; Sang Joon Kim; Deok Hee Lee; Seon-Ok Kim; Sun U Kwon; Dong-Wha Kang; Jong S Kim Journal: Eur Radiol Date: 2017-05-12 Impact factor: 5.315
Authors: D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis Journal: AJNR Am J Neuroradiol Date: 2016-07-28 Impact factor: 3.825
Authors: Vance T Lehman; Waleed Brinjikji; David F Kallmes; John Huston; Giuseppe Lanzino; Alejandro A Rabinstein; Ashima Makol; Mahmud Mossa-Bosha Journal: Br J Radiol Date: 2016-09-20 Impact factor: 3.039
Authors: Maximilian Oeinck; Christoph Rozeik; Jens Wattchow; Stephan Meckel; Manuel Schlageter; Christel Beeskow; Matthias Reinhard Journal: Neuroradiol J Date: 2016-03-17
Authors: Matthew D Alexander; Chun Yuan; Aaron Rutman; David L Tirschwell; Gerald Palagallo; Dheeraj Gandhi; Laligam N Sekhar; Mahmud Mossa-Basha Journal: J Neurol Neurosurg Psychiatry Date: 2016-01-08 Impact factor: 10.154
Authors: N J Lee; M S Chung; S C Jung; H S Kim; C-G Choi; S J Kim; D H Lee; D C Suh; S U Kwon; D-W Kang; J S Kim Journal: AJNR Am J Neuroradiol Date: 2016-09-22 Impact factor: 3.825
Authors: Seung Chai Jung; Ho Sung Kim; Choong-Gon Choi; Sang Joon Kim; Sun U Kwon; Dong-Wha Kang; Jong S Kim Journal: Clin Neuroradiol Date: 2016-09-27 Impact factor: 3.649